Lisa Weikert

Lisa Weikert

Auto-generated profile, based on publicly available information

Lisa Weikert

Department of Biomedical Sciences, Cornell University, College of Veterinary Medicine, Ithaca, NY, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2022 in Science Advances
Verified
Journal Article
Open access
MHMarlena M. Holter
Marlena M. Holter
DPDaryl J. Phuong
Daryl J. Phuong
ILIsaac Lee
Isaac Lee
MSMridusmita Saikia
Mridusmita Saikia
LWLisa Weikert
Lisa Weikert
BCBethany Cummings
Bethany Cummings
Recent studies demonstrate that α cells contribute to glucose-stimulated insulin secretion (GSIS). Glucagon-like peptide-1 receptor (GLP-1R) agonists potently potentiate GSIS, making these drugs useful for diabetes treatment. However, the role of α and β cell paracrine interactions in the effects of GLP-1R agonists is undefined. We previously found that increased β cell GLP-1R signaling activates α cell GLP-1 expression. Here, we characterized the bidirectional paracrine cross-talk by which α and β cells communicate to mediate the effects of the GLP-1R agonist, liraglutide. We find that the effect of liraglutide to enhance GSIS is blunted by α cell ablation in male mice. Furthermore, the effect of β cell GLP-1R signaling to activate α cell GLP-1 is mediated by a secreted protein factor that is regulated by the signaling protein, 14-3-3-zeta, in mouse and human islets. These data refine our understanding of GLP-1 pharmacology and identify 14-3-3-zeta as a potential target to enhance α cell GLP-1 production.